From: Patient outcomes following AKI and AKD: a population-based cohort study
 | Total number of patients | All-cause mortality | Chronic KRT | ||
---|---|---|---|---|---|
 | N | 90 days | 1 year | 90 days | 1 year |
All AKI | 56,906 | 12,623 (22.2) | 18,381 (32.3) | 213 (0.37) | 328 (0.58) |
AKI subgroup | |||||
 Community-acquired/community-managed AKI | 13,443 | 992 (7.4) | 2122 (15.8) | 48 (0.36) | 99 (0.74) |
 Community-acquired/hospital-managed AKI | 22,637 | 5946 (26.3) | 8247 (36.4) | 96 (0.42) | 135 (0.60) |
 Hospital-acquired AKI | 20,826 | 5685 (27.3) | 8012 (38.5) | 69 (0.33) | 94 (0.45) |
AKI severity | |||||
 Stage 1 | 45,361 | 9036 (19.9) | 13,694 (30.2) | 29 (0.064) | 81 (0.18) |
 Stage 2 | 7599 | 2306 (30.3) | 3003 (39.5) | 8 (0.10) | 18 (0.24) |
 Stage 3 | 3946 | 1281 (32.5) | 1684 (42.7) | 176 (4.5) | 229 (5.8) |
All AKD | 18,773 | 3695 (19.7) | 5927 (31.6) | 135 (0.72) | 205 (1.1) |